NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
55 hedge funds and large institutions have $10.1M invested in Navidea Biopharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
89% less call options, than puts
Call options by funds: $8K | Put options by funds: $75K
Holders
55
Holding in Top 10
–
Calls
$8K
Puts
$75K
Top Buyers
| 1 | +$117K | |
| 2 | +$113K | |
| 3 | +$109K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$80.1K |
| 5 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$64K |
Top Sellers
| 1 | -$131K | |
| 2 | -$106K | |
| 3 | -$104K | |
| 4 |
Millennium Management
New York
|
-$94.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$63K |